ARDT financial statements
The full income statement, balance sheet, and cash-flow statement for Ardent Health Inc. (ARDT), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Revenue | 6.32B+6.0% | 5.97B+10.3% | 5.41B+5.5% | 5.13B | |
| Selling, general & administrative | 141M+6.3% | 132M+15.5% | 115M+52.2% | 75.3M | |
| General & administrative | 141M+6.3% | 132M+15.5% | 115M+52.2% | 75.3M | |
| Amortization of intangibles | 800K | — | — | — | |
| Pre-tax income | 286M-21.1% | 363M+139.5% | 152M-51.3% | 311M | |
| Income tax | 56.2M-11.3% | 63.4M+179.9% | 22.6M-50.9% | 46.1M | |
| 136M-35.4% | 210M+290.2% | 53.9M-71.5% | 189M | ||
| Net income to non-controlling interest | 94.3M+5.5% | 89.4M+19.0% | 75.1M-1.8% | 76.5M | |
| Net income to common | 136M-35.4% | 210M+290.2% | 53.9M-71.5% | 189M | |
| $0.96-39.2% | $1.58+267.4% | $0.43-71.3% | $1.50 | ||
| EPS (basic) | $0.96-39.6% | $1.59+269.8% | $0.43-71.3% | $1.50 | |
| Weighted-avg shares (basic) | 141M+6.3% | 132M+5.0% | 126M+0.0% | 126M | |
| Weighted-avg shares (diluted) | 141M+6.6% | 133M+5.3% | 126M+0.0% | 126M | |
| Dividends per share | — | — | — | $1.39 | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 2.06B+12.3% | 1.83B+13.3% | 1.62B | — | ||
| Cash & equivalents | 710M+27.4% | 557M+27.2% | 438M-4.1% | 456M | |
| Accounts receivable | 686M-7.7% | 743M-4.2% | 775M | — | |
| Inventory | 119M+3.0% | 115M+9.1% | 105M | — | |
| Prepaid expenses | 113M-1.0% | 114M+47.2% | 77.3M | — | |
| Other current assets | 432M+42.0% | 304M+36.8% | 222M | — | |
| 5.29B+6.7% | 4.96B+4.7% | 4.73B | — | ||
| Property, plant & equipment | — | 862M+6.3% | 811M | — | |
| Goodwill | 879M+3.2% | 852M+0.9% | 845M+0.0% | 845M | |
| Intangible assets | 12.4M | — | — | — | |
| Deferred tax assets | 6.89M-44.1% | 12.3M-62.1% | 32.5M | — | |
| Other non-current assets | 112M-21.9% | 143M-2.8% | 147M | — | |
| 1.05B+10.7% | 945M-4.9% | 994M | — | ||
| Accounts payable | 458M+14.1% | 401M-15.4% | 475M | — | |
| Short-term & current debt | 23.4M+153.9% | 9.23M-50.4% | 18.6M | — | |
| Current lease liability | 53.5M+15.3% | 46.4M+9.3% | 42.4M | — | |
| Finance lease liability (current) | 11.1M+96.7% | 5.65M-9.3% | 6.24M | — | |
| 3.61B+5.0% | 3.43B-5.9% | 3.65B | — | ||
| Long-term debt | 1.08B-0.9% | 1.09B-7.1% | 1.17B | — | |
| Non-current lease liability | 1.17B+2.1% | 1.14B | — | — | |
| Operating lease liability (total) | 1.22B+2.7% | 1.19B | — | — | |
| Finance lease liability (total) | 24.5M+17.4% | 20.9M-3.7% | 21.7M | — | |
| Finance lease liability | 13.4M-12.1% | 15.3M-1.4% | 15.5M | — | |
| Other non-current liabilities | 76.6M+120.9% | 34.7M-54.3% | 76.0M | — | |
| 1.29B+13.8% | 1.13B+68.6% | 671M-35.5% | 1.04B | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | — | |
| Common stock | 1.43M+0.1% | 1.43M | 0.00 | — | |
| Additional paid-in capital | 788M+4.5% | 754M | 0.00 | — | |
| Retained earnings | 502M+37.1% | 366M+135.3% | 155M | — | |
| Accumulated other comprehensive income | -3.61M-137.1% | 9.74M-47.5% | 18.6M | — | |
| Non-controlling interest | 398M+2.2% | 390M-3.5% | 404M | — | |
| Total equity incl. non-controlling | 1.69B+10.8% | 1.52B+41.5% | 1.08B+3.4% | 1.04B | |
| Total liabilities & equity | 5.29B+6.7% | 4.96B+4.7% | 4.73B | — | |
| Common shares issued | 143M+0.1% | 143M-70.6% | 485M | — | |
| Common shares outstanding | 143M+0.1% | 143M-70.6% | 485M | — | |
| Shares outstanding (cover) | 143M+0.1% | 143M | — | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| 471M+49.4% | 315M+42.1% | 222M+678.0% | -38.4M | ||
| Depreciation & amortization | 156M+6.4% | 146M+3.9% | 141M+1.9% | 138M | |
| Intangible amortization | 800K | — | — | — | |
| Deferred income taxes | 43.6M+87.3% | 23.3M+389.7% | 4.75M-89.7% | 46.1M | |
| Change in receivables | -59.2M-47.9% | -40.0M-122.1% | 181M+953.9% | 17.2M | |
| Change in inventory | 3.15M-66.5% | 9.41M+665.0% | -1.67M+64.4% | -4.67M | |
| -214M+2.8% | -220M-59.8% | -138M-396.2% | 46.6M | ||
| Acquisitions | 2.50M-93.0% | 35.5M | 0.00 | 0.00 | |
| Other investing activities | -179K-110.5% | 1.71M+196.9% | 575K-93.4% | 8.69M | |
| -103M-519.9% | 24.6M+124.1% | -102M+62.2% | -270M | ||
| Long-term debt issued | 0.00-100.0% | 3.60M-45.6% | 6.62M+653.9% | 878K | |
| Long-term debt repaid | 7.99M-92.6% | 108M+694.2% | 13.6M-21.1% | 17.3M | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00-100.0% | 175M | |
| Other financing activities | -5.23M-199.8% | 5.24M+172.7% | -7.21M+29.9% | -10.3M | |
| Net change in cash | 153M+28.2% | 119M+742.7% | -18.5M+92.9% | -262M | |
| Income taxes paid | 36.5M-12.2% | 41.6M+114.1% | 19.4M-65.2% | 55.8M | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | |
| Market cap | 1.26B-48.2% | 2.44B | — | — | |
| P/E | 9.3×-19.8% | 11.6× | — | — | |
| P/S | 0.2×-51.2% | 0.4× | — | — | |
| P/B | 1.0×-54.5% | 2.2× | — | — | |
| Earnings yield | 10.8%+24.8% | 8.6% | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ARDT’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ARDT filings on SEC EDGAR → Not investment advice.